Vous n'êtes pas connecté
Abbott has announced that they are partnering with Medtronic Diabetes to connect a continuous glucose monitor (CGM) based on Abbott’s FreeStyle Libre tech with their insulin delivery systems The integration of Abbott’s CGM sensor with Medtronic’s AID algorithms will enable automatic adjustments of insulin to keep glucose in range. The CGM sensor, designed to work […]
In the near future, the insulin delivery devices industry is poised for remarkable advancements that promise to revolutionize diabetes management....
ABT made its CGM system Lingo available in the United States. The system can be used by consumers aged 18 years and older who are not on insulin.
INDIANAPOLIS, Sept. 10, 2024. Eli Lilly and Company today announced detailed results from the QWINT-2 phase 3 trial evaluating once-weekly insulin...
INDIANAPOLIS, Sept. 10, 2024. Eli Lilly and Company today announced detailed results from the QWINT-2 phase 3 trial evaluating once-weekly insulin...
Automated insulin delivery is the gold standard in type 1 diabetes management for children, but a lack of subsidies and the $10,000 price tag means...
MONDAY, Sept. 9, 2024 -- Insulin resistance (IR) is associated with multiple systemic diseases, according a study presented at the annual meeting of...
Diabetes affects over 37 million people in the U.S., with many of them living with type 2 diabetes. This form of diabetes used to be most common among...
Diabetes affects over 37 million people in the U.S., with many of them living with type 2 diabetes. This form of diabetes used to be most common among...